Latest News and Reviews

Protein Research Brings New Hope In Allergy-Induced Asthma Treatment

US researchers have identified a protein which is found to be a major link for asthma induced due to allergy. This finding could result into an introduction of innovative drugs for treatment of this disease.

The study conducted by lead researchers at Yale School of Medicine has reported that mice lacking the TRPA1, an ion channel protein, have shown few asthmatic symptoms.  Sven-Eric Jordt, assistance professor and lead author of the report, have pointed out in a new release that those mice without TRPA1 protein have reduced inflammation, bronchoconstriction and airway mucus.

Previous studies shown that the protein TRPA1 is likes a sensor for asthma-triggering irritants such as cigarette smoke or chemicals. This protein is actually present in airway nerve cells which triggers coughing, sneezing, irritation and controls pain.

HC-030031 drug is found to be the one which prevents pain in relation to TRPA1, thereby reducing the symptoms of asthma in mice. Jordt viewed that by blocking TRPA1 can result into prevention of lung infiltration by so called inflammatory cells which are responsible for Asthma.

The above researchers are a part of HC-030031 drug making biosciences firm which is focusing on production of new drugs for asthma.